Masaya Nagao

Prof. Masaya Nagao

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2015 in ACS Chemical Biology
Verified
Journal Article
Closed access
AOAnna Ohtera
Anna Ohtera
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
KYKotaro Yoshida
Kotaro Yoshida
KMKazuhiro Maejima
Kazuhiro Maejima
TAToru Akita
Toru Akita
MNMasaya Nagao
Masaya Nagao

7 November 2007 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
KMKeiko Momma
Keiko Momma
YMYuko Masuzawa
Yuko Masuzawa
NNNaomi Nakai
Naomi Nakai
MCMoeko Chujo
Moeko Chujo
AMAkira Murakami
Akira Murakami
MNMasaya Nagao
Masaya Nagao

1 August 2016 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
YNYukina Nishito
Yukina Nishito
NNNaomi Nakai
Naomi Nakai
YNYoko Nagumo
Yoko Nagumo
TUTakeo Usui
Takeo Usui
MNMasaya Nagao
Masaya Nagao

27 May 2019 in Molecules
Verified
Journal Article
Open access
PDF file
YUYuki Utsugi
Yuki Utsugi
HKHirona Kobuchi
Hirona Kobuchi
YKYukio Kawamura
Yukio Kawamura
AAAhmed Atito
Ahmed Atito
MNMasaya Nagao
Masaya Nagao
Yusaku MiyamaeYusaku Miyamae
Yusaku Miyamae
Covalent agonists of PPARγ cause unique receptor conformational changes and behave as selective PPARγ modulators, whereas there are few covalent agonists other than endogenous unsaturated fatty acids metabolites. Previously, we established a cell-based strategy to identify new PPARγ ligands and synthesized a new-type of covalent agonist that possesses the hybrid structure of a plant-derived cinnamic acid derivative and GW9662, a covalent antagonist. Herein, we report six analogues that differ in how the two fragments are linked together. Compounds with a simplified linker showed potent agonistic activity with improved EC50 values (less than 5 nM), indicating that close proximity between the two fragments improves binding affinity. When the position of cinnamic acid moiety was placed at 4′ carbon of aniline ring, PPARγ agonist activity was completely abolished. Docking studies suggested that the activation profile likely depends on interaction with the cavity around helix 3, β-sheet, and Ω-loop region in the ligand-binding domain. Furthermore, a cell-based assay revealed that agonist-type compounds activate PPARγ transcription in a manner dependent on covalent linkage with the Cys285 residue leading to prolonged transactivation. This activation feature reflects pharmacological benefits of covalent drugs, suggesting that these hybrid compounds may serve as potential leads for a new-class of covalent PPARγ ligands.

1 March 2021 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
MYMaho Yanagimichi
Maho Yanagimichi
KNKatsutoshi Nishino
Katsutoshi Nishino
ASAkiho Sakamoto
Akiho Sakamoto
RKRyusei Kurodai
Ryusei Kurodai
KKKenji Kojima
Kenji Kojima
MNMasaya Nagao
Masaya Nagao
The extract of Salvia officinalis (Common Sage) exhibited inhibitory activity of STAT3 signal after screening of several plants extracts using the STAT3-responsive reporter system. Cirsiliol, luteolin, and carnosol were identified from the methanol extract of Silvia officinalis as inhibitors of STAT3 signaling and the effects of these three compounds on STAT3 protein or growth inhibition on cancer cells was compared. Luteolin at the dose of 90 μM clearly suppressed the phosphorylation of STAT3 induced by IL-6, while carnosol was prone to decrease total STAT3 proteins at high doses (>90 μM). Cirsiliol had almost no effect. Since the three compounds exhibited similar concentration-dependent suppression patterns in the reporter assay except for cirsiliol became plateau beyond 30 μM, these compounds appeared to function as STAT3 inhibitory factors in different ways. The direct anti-proliferative activity of three compounds was examined with or without the anti-cancer drug gefitinib using HepG2 and A549 cells. The anti-proliferative effect of the three compounds was additively enhanced by gefitinib. At the doses of 3.6 μM, statistically significant suppression of proliferation was observed in HepG2 cells only by cirsiliol among the three compounds in the absence of gefitinib but all three compounds were prone to suppress the proliferation of HepG2 cells and A549 cells dose-dependently although cirsiliol showed a modest dose-dependency and this suppression of proliferation was enhanced by the addition of gefitinib. Cirsiliol, a dimethyoxylated flavone, activated the natural killer activity of KHYG-1 cells against erythroleukemia K562 cells like a hexamethoxylated flavone, nobiletin, suggesting that it may also have an indirect anti-cancer potential through activation of NK cells. These results shed light on the putative anti-cancer potential of Salvia officinalis.

1 January 2004 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
MYMisuzu Yamaguchi-Yamada
Misuzu Yamaguchi-Yamada
NMNoboru Manabe
Noboru Manabe
KUKozue Uchio-Yamada
Kozue Uchio-Yamada
NANaotsugu Akashi
Naotsugu Akashi
YGYasufumi Goto
Yasufumi Goto
HMHajime Miyamoto
Hajime Miyamoto
The ICR-derived glomerulonephritis (ICGN) mouse, a new inbred mouse strain with a hereditary nephrotic syndrome, is considered to be a good model of human idiopathic nephrotic syndrome and notably exhibits proteinuria and hypoproteinemia from the neonatal stage. In chronic renal disorder (CRD), anemia is a major subsequent symptom (renal anemia). The precise cause of renal anemia remains unclear, primarily owing to the lack of appropriate spontaneous animal models for CRD. To establish adequate animal models for anemia with CRD, we examined the hematological-biochemical properties and histopathological characteristics. With the deterioration of renal function, ICGN mice developed a normochromic and normocytic anemia, and exhibited normochromic and microcytic at the terminal stage. The expression of erythropoietin (EPO) mRNA both in the kidneys and liver and the EPO leak into the urine were observed in ICGN mice, indicating a disrupted metabolism of EPO in ICGN mice. In addition, a lack of iron induced by the hemolysis in the spleen and the leak of transferrin into urine as proteinuria aggravated the anemic condition. In conclusion, the ICGN mouse is a good model for anemia with CRD.